RESUMO

Introdução: A maioria dos pacientes não possui um grau satisfatório de compreensão acerca do câncer. Para que o processo de comunicação de informações seja verdadeiramente efetivo, é necessário identificar anteriormente o nível de conhecimento do paciente. Objetivo: Verificar a estabilidade teste-reteste do instrumento EORTC QLQ-INFO25 em sua versão em português do Brasil, para avaliação da necessidade de informação do paciente oncológico. Método: O instrumento foi aplicado em 253 pacientes hospitalizados nas enfermarias clínicas e cirúrgicas de um hospital de alta complexidade no tratamento do câncer situado no município do Rio de Janeiro, por meio de um questionário com entrevista individual. Para testar a adequação do processo de aferição, 85 pacientes aderiram ao reteste, com intervalo de sete a 15 dias. Os dados foram inseridos em um banco de dados por dupla digitação independente no programa Microsoft Excel. A análise foi realizada por meio da estatística Kappa simples e ponderada. Resultados: As respostas mostraram-se estáveis, e as estimativas de confiabilidade teste-reteste variaram de boas a excelentes (0,66 a 0,99). O instrumento também demonstrou boa estabilidade quando aplicado em outras populações e em pacientes com diferentes tipos de câncer. Conclusão: O instrumento EORTEC QLQ-INFO25 pode contribuir para a mensuração da satisfação do paciente em relação à sua necessidade de informação, uma vez que os resultados sugerem alta estabilidade das informações, tornando viável a sua aplicabilidade na população brasileira

Introduction: Most patients do not have a satisfactory degree of understanding about cancer. For the information communication process to be truly effective, it is necessary to identify the patient's level of knowledge beforehand. Objective: To verify the test-retest stability of the EORTC QLQ-INFO25 instrument, in its Brazilian Portuguese version, to assess cancer patient's information needs. Method: The instrument was applied in 253 patients hospitalized in the clinical and surgical wards of a highcomplexity cancer treatment hospital located in the city of Rio de Janeiro through the application of a questionnaire in an individual interview. To test the adequacy of the measurement process, 85 patients adhered to the retest, with an interval of 7 to 15 days. Data were entered into a database by independent double typing in the Excel program, and the analysis was performed using simple and weighted Kappa statistics. Results: Responses were stable, and test-retest reliability estimates ranged from good to excellent (0.66 to 0.99). The instrument also demonstrated good stability when applied to other populations and patients with different types of cancer. Conclusion: The EORTEC QLQ-INFO25 instrument can contribute for the measurement of patient satisfaction in relation to their need for information since the results suggest a high stability of information, making its applicability in the Brazilian population viable

Introducción: La mayoría de los pacientes no tiene un grado satisfactorio de conocimiento sobre el cáncer. Para que el proceso de comunicación de la información sea realmente efectivo, es necesario identificar de antemano el nivel de conocimiento del paciente. Objetivo: Verificar la estabilidad testretest del instrumento EORTC QLQ-INFO25, en su versión portuguesa de Brasil, para evaluar la necesidad de información en pacientes con cáncer. Método: El instrumento se aplicó a 253 pacientes hospitalizados en las salas clínico-quirúrgicas de un hospital de tratamiento oncológico de alta complejidad ubicado en la ciudad de Río de Janeiro mediante la aplicación de un cuestionario a modo de entrevista individual. Para probar la idoneidad del proceso de medición, 85 pacientes se adhirieron a la nueva prueba, con un intervalo de 7 a 15 días. Los datos se ingresaron en una base de datos mediante doble entrada independiente, en el programa Excel, y el análisis se realizó utilizando estadísticas Kappa simples y ponderada. Resultados: Las respuestas fueron estables y las estimaciones de fiabilidad test-retest variaron de buenas a excelentes (0,66 a 0,99). El instrumento también demostró una buena estabilidad cuando se aplicó a otras poblaciones y pacientes con diferentes tipos de cáncer. Conclusión: El instrumento EORTEC QLQINFO25 puede contribuir a la medición de la satisfacción del paciente en relación a su necesidad de información ya que los resultados sugieren una alta estabilidad de la información, viabilizando su aplicabilidad en la población brasileña

Assuntos

RESUMO

OBJECTIVE: To identify reasons among Brazilian women for never having a Pap test. DESIGN: We designed a cross-sectional study that used data from the National Health Survey. SAMPLE: Two thousand four hundred and two women 25-64 years old who never had a pap test. MEASURES: Variables were age, race, education, marital status, housing condition, primary health care access, health insurance, self-perceived health, and social support network. We calculated the prevalence of different reasons and odds ratios for each. RESULTS: The most frequent reason for never having a test were linked to women thinking the test was unnecessary (42.3%) which had a significant association with marital status (OR = 1.52; 95% CI = 1.07-1.91), age (OR = 1.56; 95% CI = 1.21-1.99), area of residence (OR = 1.15; 95% CI = 1.02-1.39), having a health insurance (OR = 1.18; 95% CI = 1.01-1.36), and self-perceived health (OR = 1.42; 95% CI = 1.28-1.56). The second most frequent reason was not knowing they needed a test (22.9%) which was associated with age (OR = 1.95; 95% CI = 1.74-2.16) and self-perceived health (OR = 1.56; 95% CI = 1.33-1.80). CONCLUSIONS: The findings suggest lack of knowledge about cervical cancer and its prevention among Brazilian women. We consider it essential that the health service can provide the test, as well as the necessary guidelines for raising the awareness of the target audience.

Assuntos

RESUMO

To describe the trends of HIV/AIDS metrics related to the burden of disease for Brazil between 1990 and 2017 we conducted a timeseries analysis for HIV/AIDS indicators by extracting data from the Global Burden of Disease study. We calculated traditional prevalence, incidence and mortality rates, the number of years lost by HIV-related deaths (YLL) and disability (YLD), and disability-adjusted life years (DALY). We estimated time series models and assessed the impact of highly active antiretroviral therapy (HAART) on the same indicators. In the set of disability-adjusted life years (DALY), the highest weight of its magnitude was due to YLL. There was a decline, especially after 1996, of DALY, mortality and YLL for HIV/AIDS. However, YLD, incidence, and prevalence increased over the same period. Also, the analysis of interrupted time series showed that the introduction of HAART into health policy had a significant impact on indicators, especially for DALY and YLL. We need to assess the quality of life of people living with HIV, especially among older adults. In addition, we need to focus on primary prevention, emphasizing methods to avoid infection and public policies should reflect this.

Assuntos